Your Mounjaro price guide · October 2026
Bydureon GLP-1: Is Bydureon a GLP-1 Medicine? (October 2026)
Yes, Bydureon is a GLP-1 medicine. Its active ingredient is exenatide, a GLP-1 receptor agonist given as a once-weekly injection for type 2 diabetes. It is not a weight-loss brand and it is not Mounjaro. Mounjaro (tirzepatide) acts on both GIP and GLP-1 receptors.1 Current as of October 2026.
One pen. Four weekly doses.
New customers£40 off your first order with code FIRST40. Standard price £169.99.
From your first consultation to ongoing care.
- GPhC-registered UK pharmacy
- Prescriber assessment
- Temperature-controlled delivery
- Advice from our pharmacy team
Bydureon and the GLP-1 class
Bydureon is a long-established GLP-1 receptor agonist for diabetes.
- Price includes prescriber assessment and standard delivery — no consultation fees
- Orders approved by 3pm for next-day tracked delivery
- GPhC-registered pharmacy 9012878
- Needles and sharps disposal included
Compare UK Mounjaro Prices
Prices checked 10 October 2026
| Provider | 2.5mg | 5mg | 7.5mg | 10mg | 12.5mg | 15mg | Notes |
|---|---|---|---|---|---|---|---|
 £40 off first order | £129.99First orderReorders £144.99 | £178.99First orderReorders £193.99 | £239.99First orderReorders £254.99 | £250.99First orderReorders £265.99 | £279.99First orderReorders £294.99 | £289.99First orderReorders £304.99 | Consultation and next-day tracked delivery included |
| Boots Online Doctor | £179.00 | £199.00 | £259.00 | £299.00 | £319.00 | £339.00 | Free click & collect; cold-chain home delivery chargeable |
| Asda Online Doctor | £148.97 | £188.97 | £248.97 | £278.97 | £287.47 | £298.97 | Refrigerated delivery from £4.50; free click & collect |
| MedExpress | £179.99 | £189.99 | £249.99 | £279.99 | £299.99 | £309.99 | Delivery £2.90 to £3.95; new-customer discount at checkout |
| Simple Online Pharmacy | £169.00 | £199.99 | £259.99 | £279.99 | £299.99 | £319.99 | Delivery £4.99 per order |
| Oxford Online Pharmacy | £143.96 | £188.96 | £248.96 | £278.96 | £288.96 | £309.95 | Free consultation; cold delivery £5.49 |
| Chemist4U | £148.00 | £188.00 | £248.00 | £278.00 | £288.00 | £298.00 | Consultation included; free temperature-controlled delivery |
| Chemist Click | £163.99 | £173.99 | £232.99 | £259.99 | £279.99 | £299.49 | Cold-chain delivery charged; £20 off with code |
| Click Pharmacy | £169.99 | £189.99 | £239.99 | £269.99 | £289.99 | £299.99 | Free assessment; delivery £3.50 to £7.95 |
| Medino | £147.99 | £169.99 | £249.99 | £269.99 | £299.99 | £319.99 | Consultation and delivery included |
Prices collected weekly from each provider's published price list.
A quick overview
What to know
before you start.
-
Bydureon contains exenatide, which belongs to the GLP-1 receptor agonist class and is used for type 2 diabetes.
-
Mounjaro (tirzepatide) activates two receptors, GIP and GLP-1, so it is not a single-action GLP-1 medicine.
-
Being in the same drug class does not make two medicines interchangeable; licences, doses and evidence differ.
-
Never swap or stop a diabetes medicine without your prescriber. Bydureon questions belong with your diabetes team.
-
If you are researching weight management, a free online consultation is reviewed by a GPhC-registered prescriber.
In this guide
01 · The short answer
Is Bydureon a GLP-1 medicine?
Yes. Bydureon is the brand name for an extended-release form of exenatide, and exenatide is a GLP-1 receptor agonist.
Bydureon is prescribed for type 2 diabetes. It is not a weight-management medicine, so it is a different decision from Mounjaro.
02 · Your next step
What should you do next?
It depends on why you are asking. If you take Bydureon now, keep taking it as directed and speak to your diabetes team before any change. If you are comparing options, our page on Bydureon versus Mounjaro sets them side by side.
If your goal is weight management and you meet the licensed criteria, you can start with our weight loss clinic.
Related guides: Agonisti glp 1 and Trapezoid glp 1.
03 · GLP-1 versus dual action
How a GLP-1 medicine differs from Mounjaro
A single-action GLP-1 medicine targets one gut-hormone receptor. Tirzepatide is the first treatment of its kind to activate two natural gut-hormone receptors at once: GIP and GLP-1.1 Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin.
That dual action is what distinguishes Mounjaro from single-action GLP-1 medicines such as semaglutide (Wegovy/Ozempic).1
04 · What Mounjaro is licensed for
What Mounjaro is licensed for
Mounjaro is the brand name for tirzepatide, a once-weekly injectable prescription medicine made by Eli Lilly. In the UK it is licensed for weight management in adults and for type 2 diabetes.1 It comes as a pre-filled multi-dose pen (KwikPen) in six strengths: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg.1
In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.2 These are trial averages, and individual results vary.
05 · Related GLP-1 terms
Related GLP-1 terms people confuse
Ozempic is semaglutide licensed for type 2 diabetes only; it is not a UK weight-loss medicine, and prescribing it privately for weight loss is off-label. Supplement claims such as AMPK and GLP-1 describe body pathways, not a licensed medicine. Other manufacturers' pipelines, for example Boehringer Ingelheim's GLP-1 work, are separate again.
Medicines in development or with no UK licence should not be treated as options. Only a prescriber can tell you what is appropriate for you.
06 · NHS and private access
NHS and private access to weight-management injections
Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first (initially BMI 40+ with four or more qualifying conditions).4 Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting.
Mounjaro is a prescription-only medicine, supplied only after an online consultation reviewed by a GPhC-registered prescriber. It is used alongside a reduced-calorie diet and increased physical activity.
How ordering works
How ordering works at EverydayMeds
Three steps, with our pharmacy team alongside you.
Step 1: Online consultation — 5–10 minutes
Complete a confidential health questionnaire covering BMI, medical history and current medication. No payment is taken until you're approved.
Step 2: Prescriber review — usually same day
A UK registered prescriber checks your suitability against the licensed criteria (BMI ≥30, or ≥27 with a weight-related condition) and contraindications, and confirms your starting dose.
Step 3: Next-day tracked delivery
Dispensed by our GPhC-registered pharmacy in temperature-controlled packaging with needles and a sharps bin included. Orders approved by 3pm for next-day tracked delivery.
Prescription and dispatch follow clinical approval. Confirm current delivery options when ordering.
Afterwards you're not on your own: dose-change reviews are built in before each step up, our pharmacist team is available for side-effect questions, and repeat orders re-check suitability rather than auto-shipping.
Your questions, answered
Mounjaro price UK — frequently asked questions
Answers to common questions about Mounjaro prices, NHS access and ongoing treatment.
Ask our pharmacy teamIs Bydureon a GLP-1?
Is Bydureon the same as Mounjaro?
Which diabetes medicine should I take?
What is the wonder drug for diabetes?
Which snacks and biscuits are okay for diabetics?
Can I get Mounjaro if I have used a GLP-1 like Bydureon?
Clinically reviewed by
Mahommed Zunaid Ayub Patel
Superintendent Pharmacist
Accountable for the safe running of our registered pharmacy — from dispensing checks to delivery.
GPhC registration no. 2217101 · check the GPhC register
- Reviewed
- Last updated
- Next review
How we source our information
How we source our information: every clinical statement on this page is drawn from the sources below. Our prices are shown live from our pharmacy's product listings, and competitor prices show the date they were collected.
Sources — 4 references
- Mounjaro KwikPen — Summary of Product Characteristics (SmPC), electronic medicines compendium (EMC), 2026
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med 2022;387:205–216
- NICE TA1026 — Tirzepatide for managing overweight and obesity, including the practical prescribing guide
- NHS England — Weight management injections: rollout guidance
EverydayMeds is operated by OVIO Ltd · GPhC-registered pharmacy 9012878 · Registered premises, Leicester · Superintendent Pharmacist: Mahommed Zunaid Ayub Patel